Original Publication Date: 1 September, 2014
Publication / Source: International Journal of Endocrine Oncology
Authors: Anthony R Glover, James C Lee, Stan B Sidhu
Patients who are diagnosed with differentiated thyroid cancer (DTC) have favorable survival rates of over 90%; however, up to 30% of them develop recurrent disease leading to considerable morbidity . Multiple prognostic systems have been developed for thyroid cancer, which are effective in predicting mortality, but not as effective in predicting recurrence .